BSE INFLUXSME boardHealthcare (Pharma CDMO)

Influx Healthtech Limited

Healthcare (Pharma CDMO) · Updated 14 Oct 2026

Observed activity5.7/10Moderate observable activity
Share price₹265Market cap ₹613 Cr

Influx Healthtech Limited overview

Digital presence

The official website influxhealthtech.com was reviewed on 14 Oct 2026 and uses HTTPS, is mobile-friendly, has an investor relations section.

A LinkedIn page was found with 948 followers and 45 employees listed; 11 posts recorded in the last 90 days, latest 2 days ago.

An Instagram account was found with 828 followers, 9 posts in the last 90 days, latest 12 Oct 2026.

A Facebook page was found with 92 followers.

Information not available

  • Facebook posts in 90 days: not captured
  • X account: not found
  • YouTube channel: not found

Presence Radar

Reviewed 14 Oct 2026
5.7overallWWebsite5inLinkedIn7IGInstagram6fFacebook2
Website 5LinkedIn 7Instagram 6Facebook 2

Moderate observable activity. Colour shows the level of observed activity: higher, moderate, limited. Not a judgement of the company. Methodology v0. How it works

Website

5/10

influxhealthtech.com

Website checks

✓HTTPSYes
✓Mobile friendlyYes
✓Investor relations sectionPresent
?Footer copyright yearNot shown
?Mobile page speed (0–100)Not captured

Social channels

Follower counts can be purchased; shown for reference only.

LinkedIn

7/10
Followers948
Employees listed45
Posts, 90 days11
Avg engagement12
Last post2 days ago

linkedin.com/company/influx-healthtech

Instagram

6/10
Followers828
Posts, 90 days9
Avg engagement35
Last post12 Oct 2026

instagram.com/influxhealthtech

Facebook

2/10
Followers92

facebook.com/influxhealthtech

Market snapshot prototype data

52-week low
₹16652-week high
₹315
Price₹265
Market cap₹613 Cr
All-time high₹302.75
Below all-time high12.5%
P/E29.9
Promoter holding73.53%
Dividend yield0%

Source: research sheet (14 Oct 2026). Market data still needs a licensed source before public launch.

Prototype data. Details may be incomplete or out of date. Verify with official filings and exchange disclosures.